An open-label prospective interventional study to assess the prophylactic effect of Guduchi Ghan Vati in COVID-19: A community-based study in containment zone of Himachal Pradesh, India

Kavita Vyas, Anubha Chandla, Vikas Nariyal, B. Yadav, Hetalben Amin, S. Khanduri, B. Sharma, Rakesh Rana, R. Singhal, Arunabh Tripathi, B. Chandrasekhararao, Narayanam Srikanth, K. Dhiman
{"title":"An open-label prospective interventional study to assess the prophylactic effect of Guduchi Ghan Vati in COVID-19: A community-based study in containment zone of Himachal Pradesh, India","authors":"Kavita Vyas, Anubha Chandla, Vikas Nariyal, B. Yadav, Hetalben Amin, S. Khanduri, B. Sharma, Rakesh Rana, R. Singhal, Arunabh Tripathi, B. Chandrasekhararao, Narayanam Srikanth, K. Dhiman","doi":"10.4103/jras.jras_153_22","DOIUrl":null,"url":null,"abstract":"BACKGROUND: Several studies have proven the immunomodulatory action of Guduchi (Tinospora cordifolia). Immunomodulation strategy is a crucial requirement to control coronavirus disease 2019 (COVID-19), the disease caused by severe acute respiratory syndrome coronavirus 2. Therefore, Guduchi Ghan Vati (GGV), tablets prepared from water extract of T. cordifolia, is selected to prevent COVID-19. OBJECTIVE: This study aimed to know the prophylactic effect of Ayurvedic intervention, that is GGV, in preventing COVID-19 infection among the community of containment areas. MATERIALS AND METHODS: It was an open-label, prospective, nonrandomized, community-based interventional study carried out from May 6 to June 23, 2020, in a containment zone (Bijhari) of District Hamirpur, Himachal Pradesh, India. GGV was given to the community in the dose of 500 mg twice a day with lukewarm water on an empty stomach for 30 days. The demographic and health-related data of the participants were collected using Google forms, and follow-up was done on the 30th day through telephonic interviews. RESULTS: A total of 1165 participants’ data were analyzed to assess the prophylactic effect of GGV. In the sample, 85.2% of participants had no systemic disorders, whereas 13.8% took concomitant medicines for other morbidities. The incidence of COVID-19-positive cases was only 0.1% (n = 01). CONCLUSION: Ayurvedic intervention GGV was found to have prophylactic potential against COVID-19 infection.","PeriodicalId":394246,"journal":{"name":"Journal of Research in Ayurvedic Sciences","volume":"12 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Research in Ayurvedic Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/jras.jras_153_22","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

BACKGROUND: Several studies have proven the immunomodulatory action of Guduchi (Tinospora cordifolia). Immunomodulation strategy is a crucial requirement to control coronavirus disease 2019 (COVID-19), the disease caused by severe acute respiratory syndrome coronavirus 2. Therefore, Guduchi Ghan Vati (GGV), tablets prepared from water extract of T. cordifolia, is selected to prevent COVID-19. OBJECTIVE: This study aimed to know the prophylactic effect of Ayurvedic intervention, that is GGV, in preventing COVID-19 infection among the community of containment areas. MATERIALS AND METHODS: It was an open-label, prospective, nonrandomized, community-based interventional study carried out from May 6 to June 23, 2020, in a containment zone (Bijhari) of District Hamirpur, Himachal Pradesh, India. GGV was given to the community in the dose of 500 mg twice a day with lukewarm water on an empty stomach for 30 days. The demographic and health-related data of the participants were collected using Google forms, and follow-up was done on the 30th day through telephonic interviews. RESULTS: A total of 1165 participants’ data were analyzed to assess the prophylactic effect of GGV. In the sample, 85.2% of participants had no systemic disorders, whereas 13.8% took concomitant medicines for other morbidities. The incidence of COVID-19-positive cases was only 0.1% (n = 01). CONCLUSION: Ayurvedic intervention GGV was found to have prophylactic potential against COVID-19 infection.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
评估Guduchi Ghan Vati对COVID-19预防效果的开放标签前瞻性干预研究:印度喜马偕尔邦控制区的社区研究
背景:一些研究已经证实了古杜芝(Tinospora cordifolia)的免疫调节作用。免疫调节策略是控制由严重急性呼吸综合征冠状病毒引起的2019冠状病毒病(COVID-19)的关键要求。因此,我们选择以堇青花水提取物制成的Guduchi Ghan Vati (GGV)片剂来预防COVID-19。目的:了解阿育吠陀干预(GGV)在防控区域社区COVID-19感染中的预防作用。材料和方法:这是一项开放标签、前瞻性、非随机、基于社区的干预性研究,于2020年5月6日至6月23日在印度喜马偕尔邦哈米尔普尔区(Bijhari)的一个隔离区进行。GGV的剂量为500毫克,每天两次,用温水空腹给药,持续30天。使用谷歌表格收集参与者的人口统计和健康相关数据,并在第30天通过电话访谈进行随访。结果:共分析了1165名参与者的数据,以评估GGV的预防作用。在样本中,85.2%的参与者没有全身性疾病,而13.8%的参与者同时服用其他疾病的药物。新冠病毒阳性病例发生率仅为0.1% (n = 01)。结论:阿育吠陀干预GGV对COVID-19感染具有预防作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
V. M. Kuṭṭikṛṣṇa Mēnōn: An unmatched scholar of traditional Ayurveda system of medicine Epic journey of Prof.Vaidya Shriram Sharma Evincing Ayurveda to the World “Vidyarthimitra” Vaidya Madhav Vasudev Kolhatkar: A mentor who has empowered generations of physicians Avanapparambu Maheswaran Namboothirippad – a life which preserved the knowledge of Ayurveda Vishachikitsa and Hastyayurveda Ms. Savita Satakopan—A doyen of research in the field of Pharmacognosy
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1